A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study (Q34628840)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study |
scientific article |
Statements
1 reference
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study (English)
1 reference
G Grignani
1 reference
E Palmerini
1 reference
P Dileo
1 reference
S D Asaftei
1 reference
L D'Ambrosio
1 reference
Y Pignochino
1 reference
M Mercuri
1 reference
P Picci
1 reference
F Fagioli
1 reference
P G Casali
1 reference
S Ferrari
1 reference
M Aglietta
1 reference
28 April 2011
1 reference
1 reference
23
1 reference
2
1 reference
508-516
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference